MSB

4.69%

$1.45 mesoblast limited

Yeah there's always risks involved in any invasive...

First 509 Last

Share
Profile

Follow
DocMcstuffins

7,872 Posts.

1354

12/05/22

11:17

Post #: 61362694
Share

Originally posted by Martin37: ↑

"Continue to be unpleasantly surprised"

Really, what are you going to do, impersonate a Cardiologist next.

Real doctors have no problem prescribing/treating in hospitals.

Most of us here know you are a Quack.

Remember not too long ago when you were harping on that Rex-L would be best given as a systemic IV infusion because of the increased difficulty in performing an IM injection directly into the myocardium (to translate for non-doctors like yourself that means an Intra Muscular injection into the heart muscle)? This reasoning you gave among others was a dead giveaway that you don't understand stem cells or medicine even close to the level of a real doctor in this space. I am certain that Perin and any other cardiologist would agree. Wasn't it obvious to you that a trained cardiologist would not find such an injection into the myocardium as difficult that you implied? The IM injection procedure was performed very well in the DREAM trial, wasn't it? What's more, did it not also occur to you that an IM injection into the myocardium would favourably bypass the lungs and most importantly increase the exposure time directly where the cells are actually needed?

And on this forum you continue to lecture holders of their 'incorrect' thinking (some maybe justified but also there are also times when you have the 'incorrect' thinking IMHO). Maybe it is you that should take a close look in the mirror. You are certainly not the most informed person on this forum. Not even close. Period.

Did you not consider that the holders may instead be pleasantly surprised (as opposed to your view in bold above). You do realise that MACE (Major Adverse Cardiac Events) is an accepted outcome. You do know that the FDA asked Mesoblast for further information. You do know that the trial for CLBP is only 12 months and will start the second half of this year. You do know that there is a very good chance we will get a major partner in the next 12 months for either CHF, CLBP, Crohns or even COVID (when the potency assays and ticked off).

Obviously there is a motive when one only focuses their discussion on the 'unpleasant surprises' without taking at least a quarter of the time to discuss the 'potential' as well. This is what us (not you) as holders have hopefully done - done a thorough risk/reward analysis, and why the vast majority are happy to hold (and accumulate) at these prices.

Expand

Yeah there's always risks involved in any invasive procedure, especially cardiac catheterisation.

MSB Price at posting: 99.3¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

IMA

Issues emerging as Australian companies tackle critical minerals challenge

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

There are more pages in this discussion • 647 more messages in this thread...

First 509 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.45		Change 0.065(4.69%)		Mkt cap ! $1.655B

Open	High	Low	Value	Volume
$1.39	$1.50	$1.38	$7.016M	4.856M

Buyers (Bids)

No.	Vol.	Price($)
1	10425	$1.44

Sellers (Offers)

Price($)	Vol.	No.
$1.45	44243	5

View Market Depth

No.	Vol.	Price($)
1	10425	1.440
2	9000	1.435
4	62190	1.430
1	473	1.425
1	5000	1.420

Price($)	Vol.	No.
1.450	16999	2
1.455	17000	1
1.465	24896	3
1.470	112738	6
1.475	1800	1

Last trade - 16.10pm 11/10/2024 (20 minute delay)

MSB (ASX) Chart

Yeah there's always risks involved in any invasive...

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Issues emerging as Australian companies tackle critical minerals challenge

Cauldron Energy reports "excellent" uranium assays in latest drill run

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yeah there&apos;s always risks involved in any invasive...

Top Stories

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Issues emerging as Australian companies tackle critical minerals challenge

Cauldron Energy reports "excellent" uranium assays in latest drill run

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yeah there's always risks involved in any invasive...